Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000772

Drug Information
Synonyms2-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-4h-chromen-4-one; Mini Sintrom; MLS001074461; Acenocoumarol Alliance Brand; Sintrom; Synthrom; ACENOCOUMAROL; EINECS 205-807-3; LS-55093; Prestwick3_000110; Ciba-Geigy Brand of Acenocoumarol; Nitrowarfarin; Ascumar; AC1Q1Z5F; Neositron; Sinthrome; Sinthrom; Prestwick1_000110; CHEMBL397420; BPBio1_000110; Sincoumar; 3-(alpha-Acetonyl-para-nitrobenzyl)-4-hydroxy-coumarin; G-23,350; Acenocoumarolum; Acenocoumarol [INN]; 4-Hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-2H-1-benzopyran-2-one; Minisintrom; AB-014/25000129; CHEMBL145253; 3-(alpha-(p-Nitrophenol)-beta-acetylethyl)-4-hydroxycoumarin; Acenokumarin [Czech]; 70897-81-3; CHEBI:53766; Prestwick0_000110; 3-(alpha-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin; AC1L1S7P; BRD-A65051990-001-03-8; Acenokumarin; Syntrom; HMS1568E22; 3-(alpha-(4'-Nitrophenyl)-beta-acetylethyl)-4-hydroxycoumarin; Sinkumar; Acenocumarolo; Acenocumarolo [DCIT]; Nitrophenylacetylethyl-4-hydroxycoumarine; Novartis Brand of Acenocoumarol; Nitrovarfarian; Sintroma; Syncumar; Prestwick2_000110; 4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one; CID9052; SPBio_002039; Acenocoumarolum [INN-Latin]; 2H-1-Benzopyran-2-one, 4-hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-; UNII-I6WP63U32H; D000074; Acenocumarolum; D07064; Mini-sintrom; Alliance Brand of Acenocoumarol; 2-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]chromen-4-one; Acenocoumarol (INN); 152-72-7; Jsp002948; Coumarin, 3-(alpha-acetonyl-p-nitrobenzyl)-4-hydroxy-; NCGC00179658-01; Nicumalon; 3-(alpha-Acetonyl-p-nitrobenzyl)-4-hydroxycoumarin; BSPBio_000100; Zotil; Nicoumalone; 2H-1-Benzopyran-2-one, 4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-; Ciba Geigy Brand of Acenocoumarol; SMR000162652; Prestwick_773; Syncoumar; Mini-sintrom (TN); G 23350; Acenocoumarol Ciba-Geigy Brand; AB00513804; Acenocoumarin; C19H15NO6; DB01418; Acenocoumarol Novartis Brand; HSDB 3201; MLS000539171; 3-(alpha-p-Nitrophenyl-beta-acetylethyl)-4-hydroxycoumarin; G23350; 2H-1-Benzopyran-2-one, 4-hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-, (+-)-; MolPort-002-798-798; G-23350; AR-1E2350; Acenocumarol    
Trade NameSintrom; Sinthrome    
IndicationThrombosisApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassAnticoagulants    
CAS NumberCAS 152-72-7
PubChem Compound IDCID 9052.    
PubChem Substance IDSID 152231.    
SuperDrug ATC IDB01AA07;    
SuperDrug CAS ID000152727;    
TargetVitamin K epoxide reductase complex subunit 1Inhibitor[2][3][4]
Ref 1Drug information of Acenocoumarol, 2008 To Reference
Ref 2Evaluation of a reverse-hybridization StripAssay for the detection of genetic polymorphisms leading to acenocoumarol sensitivity. Mol Biol Rep. 2009 Jun 28. [Epub ahead of print] To Reference
Ref 3Genotypes associated with reduced activity of VKORC1 and CYP2C9 and their modification of acenocoumarol anticoagulation during the initial treatment period. Clin Pharmacol Ther. 2009 Apr;85(4):379-86. Epub 2009 Feb 18. To Reference
Ref 4Oral anticoagulation and pharmacogenetics: importance in the clinical setting. Rev Med Suisse. 2007 Sep 12;3(124):2030, 2033-4, 2036. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543